Back
Monopar Therapeutics Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
MNPR
Monopar Therapeutics
Last Price:
$41.84
Seasonality Move:
-14.17%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Monopar Therapeutics Stock Forecast
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 167.8% based on the past 5 years of stock performance.
-
Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Monopar Therapeutics Stock Undervalued?The current Monopar Therapeutics [MNPR] share price is $40.33. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 167.8% based on the past 5 years of stock performance.
Monopar Therapeutics Stock Rating
Sell
48
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics overpriced?
-
Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Monopar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
54.30
52-Week Low:
1.72
Prediction Charts
Market Cap:
212.9M
Price in USD:
40.33
Volume:
17.7K
Beta:
1.37
Technical Analysis
SMA50:
37.86
SMA100:
29.65
SMA200:
17.05
52-Wk Change:
1084.43%
Stock Predictions
-
Is Monopar Therapeutics stock public?Yes, Monopar Therapeutics is a publicly traded company.
-
What is the Monopar Therapeutics stock quote today?The Monopar Therapeutics stock price is 40.33 USD today.
-
How to buy Monopar Therapeutics stock online?You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-11 | 27.34 | 29.28 | 31.29 | 27.34 |
| Mar-12 | 30.51 | 30.90 | 34.11 | 30.20 |
| Mar-13 | 31.35 | 29.49 | 31.90 | 29.49 |
| Mar-14 | 29.49 | 29.75 | 30.99 | 29.49 |
| Mar-17 | 29.57 | 34.23 | 34.88 | 29.53 |
| Mar-18 | 34.00 | 34.37 | 35.35 | 31.30 |
| Mar-19 | 36.56 | 39.10 | 42.96 | 34.50 |
| Mar-20 | 38.09 | 44.74 | 47.83 | 38.09 |
| Mar-21 | 46.00 | 40.00 | 46.00 | 35.46 |
| Mar-24 | 42.00 | 37.60 | 42.83 | 34.13 |
| Mar-25 | 36.37 | 37.58 | 38.49 | 35.63 |
| Mar-26 | 37.99 | 38.10 | 38.23 | 36.86 |
| Mar-27 | 37.51 | 41.39 | 43.00 | 36.80 |
| Mar-28 | 40.21 | 40.33 | 42.68 | 37.25 |
Monopar Therapeutics Earnings
Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics Forecast Revenue Growth
Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.